U.S. Department of Health and Human Services
Oliver Blondel
 

 Contact Info

 
Tel: 301-451-7334
Email: blondelol@mail.nih.gov
 

 Select Experience

 
  • Senior ScientistHuman Genome Sciences2001-2004
  • Visiting ScientistNINDS/NIH1997-2000
  • Research AssociateINSERM U-446, Chatenay-Malabry, France1994-1997
  • Postdoctoral FellowUniversity of Chicago1990-1994
  • Ph.D.University of Paris 7, France1989

Current Responsibilities & Activities

My primary interests lie in research that focuses on endocrine signaling, stem cell biology, organ development, regenerative medicine and biomarker discovery as it relates to diabetes (type 1 and type 2) and metabolic diseases, particularly in combination with experimental approaches such as large-scale genomics, chemical biology, synthetic biology, bioengineering, epigenetics, nuclear organization of mammalian genomes, chromatin biology, genome editing, gene therapy and single-cell analysis. My portfolio is composed of grants that combine two or more of the areas and technologies described above, and cannot easily be assigned to other portfolios within DEM.
 
Besides the management of a grant portfolio, my administrative responsibilities include: Project Scientist, Beta Cell Biology Consortium (BCBC); Project Scientist, Human Islet Research Network (HIRN); NIDDK representative, Network for Pancreatic Organ Donors (nPOD); Program Director, Accelerating Medicines Partnership for Type-2 Diabetes (AMP-T2D) Consortium; Coordinator, 4D Nucleome Common Fund Program.
 

​Research Programs

Endocrine Pancreas
The Endocrine Pancreas program supports research on the basic biology, development, and function of the endocrine pancreas as well as clinical studies on islet transplantation for the treatment of type 1 diabetes

Pathophysiology of Diabetes and Metabolic Disease
This program supports basic and clinical research that addresses the pathophysiology of metabolic diseases, including the etiology of type 1 diabetes and other autoimmune endocrine diseases